We realize that COVID-19 has created challenges and uncertainty within the healthcare system, especially for those patients trying to determine which treatment options may be available. To help provide some clarity during this time, we’ve contacted centers around the country to confirm how they are handling the pandemic and how it is affecting enrollment for their multiple myeloma clinical trials. The table below outlines the responses we’ve compiled so far. It includes the enrollment status for each center and the date of the last updated received. We will continue to work with centers to update this on an on-going basis. If you have questions or need further help, we're here for you. Please call us for help (888) 828-2206.
The Myeloma Crowd is opening the largest COVID-19 multiple myeloma patient study. Myeloma patients can make a valuable contribution to fighting COVID-19 and receive a free antibody test. We can join together to quickly answer critical questions to help us get through the COVID-19 crisis and come out stronger, healthier and more knowledgeable in the process.